Frazier Lifesciences Acquisition Corporation Warrant
FLACW
FLACW was delisted on the 22nd of November, 2022.
29 hedge funds and large institutions have $2.38M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
21% more funds holding
Funds holding: 24 → 29 (+5)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
55% less capital invested
Capital invested by funds: $5.29M → $2.38M (-$2.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$105K |
| 2 |
CAC
Cowen and Company
New York
|
+$87.9K |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$30.7K |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$15.4K |
| 5 |
Walleye Capital
New York
|
+$13.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.51M |
| 2 |
AC
Athanor Capital
New York
|
-$525K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.23K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$140 |
FLACW Hedge Fund Activity: Q4 2021 in Review
29 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q4 2021, worth a combined $2.38M — down 55% from $5.29M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new FLACW positions and 2 closed out — a net gain of 5 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Ensign Peak Advisors, opening a new position worth an estimated $105K. The largest seller was Monashee Investment Management, exiting entirely with an estimated $2.51M sold.
- 29 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q4 2021, up from 24 in Q3 2021.
- Funds reported $2.38M of Frazier Lifesciences Acquisition Corporation Warrant stock for Q4 2021, down 55% quarter-over-quarter.
- 7 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q4 2021 and 2 closed out, a net change of +5 holders.
- The largest Frazier Lifesciences Acquisition Corporation Warrant buyer in Q4 2021 was Ensign Peak Advisors, an estimated $105K added.
- The largest Frazier Lifesciences Acquisition Corporation Warrant seller in Q4 2021 was Monashee Investment Management, an estimated $2.51M sold.
Based on aggregated 13F filings for Q4 2021.